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Abstract 
Myotoxin II, a myotoxic alcium-independent phospho- 
lipase-like protein isolated from the venom of Bothrops 
asper, possesses no detectable phospholipase activity. 
The crystal structure has been determined and refined at 
2.8A to an R factor of 16.5% (F>3o') with excellent 
stereochemistry. Amino-acid ifferences between cataly- 
tically active phospholipases and myotoxin II in the 
Ca2+-binding region, specifically the substitutions 
Tyr28~Asn, Gly32~Leu and Asp49~Lys, result in 
an altered local conformation. The key difference is that 
the e-amino group of Lys49 fills the site normally 
occupied by the calcium ion in catalytically active 
phospholipases. In contrast o the homologous mono- 
meric Lys49 variant from Agkistrodon piscivorus 
piscivorus, myotoxin II is present as a dimer both in 
solution and in the crystalline state. The two molecules in 
the asymmetric unit are related by a nearly perfect wo- 
fold axis, yet the dimer is radically different from the 
dimer formed by the phospholipase from Crotalus atrox. 
Whereas in C. atrox the dimer interface occludes the 
active sites, in myotoxin II they are exposed to solvent. 
Introduction 
Phospholipases A2 (PLA2, E.C. 3.1.1.4) are small stable 
calcium-dependent hydrolytic enzymes that specifically 
hydrolyze the sn2 ester of phospholipids (Deenen & de 
Haas, 1964), preferentially in lamellar or micellar 
aggregates atmembrane surfaces (reviewed by Raminez 
& Jain, 1991). These enzymes are widely distributed in 
nature and have been extensively studied (Dennis, 1983; 
Waite, 1987). The extracellular PLA 2,s occur abundantly 
in mammalian pancreatic juice and in the venoms of 
snakes and insects. The intracellular PLA2's, which are 
often membrane associated, are involved in blood 
platelet aggregation and inflammation (Scott et al., 
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1990). The catalytic activity of these intracellular 
enzymes results in the release of arachidonic acid, a 
precursor of eicosanoids, and is implicated in triggering 
inflammatory eactions (Scott et al., 1990). 
Despite the diversity of occurrence, the primary 
sequence of all PLA's demonstrate considerable se- 
quence homology and are divided into two classes on the 
basis of location of disulfide bridges and loop lengths. 
Class I PLA2's include pancreatic and elapid venom 
enzymes, whereas class II are found in crotalid and viper 
venom PLA2's (Dufton & Hider, 1983). 
Recently, a sub-class of snake-venom PLA2-1ike 
proteins which retain cytotoxicity, but lack phospholi- 
pase activity have been identified and sequenced 
(Maraganore t al., 1984; Maraganore, Poorman & 
Heinrickson, 1987; Yoshizumi et al., 1990; Liu et al., 
1990; Homsi-Brandenburgo, Queiroz, Santo-Neto, 
Rodrigues-Simon & Giglio, 1988; Francis, Gutierrez, 
Lomonte & Kaiser, 1991). In the catalytically active 
PLA2, calcium is an essential co-factor, and the non- 
catalytic PLA2-1ike proteins are primarily characterized 
by the substitution of Asp49 by Lys. In all catalytically 
active PLAz's, Asp49 plays a central and essential role in 
catalysis by contributing two carboxylate O atoms to the 
calcium ligation cage. The Asp49~Lys49 substitution 
results in the e-amino group of lysine filling the site 
normally occupied by the calcium ion (Holland et al., 
1990; Scott, Achari, Vidal & Sigler, 1992) resulting in 
the loss of calcium binding. Although initial results 
suggested that the Lys49 variant isolated from Agkis- 
trodon piscivorus piscivorus (App) demonstrated a low 
level of PLA2 activity (Maraganore t al., 1984), it has 
subsequently been shown that this is due to trace 
contamination by other active PLA2 species (Dhillon et 
al., 1987; van den Berg, Slotboom, Verheij & de Haas, 
1989). 
The interaction of Bothrops asper myotoxin II with 
liposomes of diverse composition provokes rapid and 
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extensive release of the aqueous contents. Previous work 
(Rufini et al., 1992) has established that, (a) this process 
is Ca 2+ independent and occurs without detectable 
phospholipid hydrolysis. (b) Whereas catalytically active 
phospholipases are unable to induce liposome leakage in 
the absence of Ca 2÷, the addition of Ca 2+ results in 
liposome leakage with concomitant hydrolysis of 
phospholipids. (c) The kinetics of the Ca2+-dependent 
and independent liposome leakage indicate the existence 
of different mechanisms of interaction with the lipid 
bilayer. In conclusion, it is suggested that a new type of 
cytolytic reaction mechanism is responsible for the 
effects of myotoxin II in vivo (Rufini et al., 1992). 
In the hope of providing an insight into this novel 
mechanism, we have determined the structure of 
myotoxin II, a myotoxic Lys49 variant from the venom of 
B. asper. The model we present has been determined 
at 2.8A resolution and refined to a crystallographic 
residual of 16.5% (F>3o'). The structural changes 
caused by amino-acid substitutions in the calcium- 
binding loop are examined and compared to the structure 
of the Lys49 variant from App. In addition, myotoxin II 
exists as a dimer in solution, and the structure we present 
here provides an insight as to the nature of the dimer 
interface. 
Experimental methods 
The Lys49 PLA2 from B. asper was isolated (Lomonte & 
Gutierrez, 1989) and the protein (5.0mg ml -~) was 
crystallized from 0.1 M citrate, 20% 2-propanol using 
20% PEG 4000 as a precipitant (Arni & Gutierrez, 1993). 
Crystals belong to space group P2~2121 with cell 
constants a = 50.18, b = 67.76 and c = 88.00,~,. 
X-ray diffraction data was collected from a single 
crystal using a Rigaku RU200 generator operated at 
50kV and 150mA and a Xentronics area detector 
(Siemens). The data was processed using the program 
XENGEN (Howard et al., 1987). An Rmerge on intensities 
of 0.056 was obtained for 5805 unique reflections from a 
total of 23 021 observations. Table 1 summarizes the 
crystallographic data and refinement statistics. 
The structure was solved by molecular-replacement 
techniques using the program package MERLOT (Fitz- 
gerald, 1988). The search model, which consisted of 887 
atoms, was derived from the Lys49 variant from App 
(Holland et al., 1990). Structure factors were calculated 
in a cubic cell with P1 symmetry and edge dimensions of 
120,4,. Data with I > 3o. between 8.0 and 4.0 ,~ was used 
coupled with a radius of integration of 23.9 ,~,. The two 
highest peaks in the cross-rotation function map were 
6.2o" and 4.5o'. Correlation with the self-rotation results 
revealed the orientation of the two molecules in the 
asymmetric unit. The orientation angles were refined 
using the Lattman rotation function (Lattman & Love, 
1972) with angular increments of a = 1.0, /~ -- 1.0 and 
y = 2.0 °. The highest peaks in the Crowther & Blow 
Table 1. Summary of crystallography data and refine- 
ment statistics 
Space group 
Cell constants (,~) 
No. of observations 
No. of unique reflections 
Rmerge 
Refinement statistics 
Resolution (.~) 
No. of reflections 
R factor (%) 
No. of protein atoms 
No. of solvent atoms 
P2t2121 
a = 50.18(2) 
b = 67.76 (3) 
c = 88.00 (4) 
23021 
5805 
0.056 
7.0-2.8 
4915 
16.5 
1890 
69 
R.m.s. deviations from ideal values 
Bond lengths (/~) 0.010 
Bond angles (o) 2.107 
Dihedral (°) 27.948 
lmpropers (°) 6.661 
translation function (Crowther & Blow, 1967) with o. 
values between 7.9 and 5.0 produced a model with an 
acceptable number of close contacts. The rotational and 
translational parameters were optimized by utilizing the 
R-factor minimization procedure as implemented in 
MERLOT (Fitgerald, 1988) which reduced the R factor 
from 52.0 to 48.1% in the 6.0--3.5 ,~ resolution range. 
Energy minimization and refinement using X-PLOR 
(Brtinger, o1988) resulted in an R factor of 23.9% in the 
10.0--2.8A resolution range. The electron-density map 
was then examined using FRODO (Jones, 1985) and all 
the side-chain atoms were included. An additional round 
of simulated annealing resulted in a crystallographic 
residual of 21.2% (7.0-2.8,~). Numerous simulated- 
annealing omit maps were computed to permit the 
determination of the conformation of poorly determined 
loop regions (see results) and three additional rounds of 
Fig. 1. Ribbon representation of the structure the mytoxin II monomer. 
The N terminus (N) and C terminus (C) are labelled. 
model building and refinement were carried out. The 
individual temperature factors were refined and the 
refinement converged to a final residual of 16.5% 
(F>3cr) for 4915 reflections between 7.0 and 2.8,~. 
The final model consisted of 1890 protein atoms and 69 
solvent O atoms. 
Results 
50 . . . . . . . . . .  
The asymmetric unit of the myotoxin II crystal contains 
two monomers with near-perfect wofold rotational 
symmetry (see below). The ribbon diagram presented 
in Fig. 1 presents the fold of the myotoxin II monomer. 
The structure is similar to those of PLA2's isolated from 
other snake species (Brunie, Bolin, Gewirth & Sigler, 
1985; Holland et al., 1990; White, Scott, Otwinowski, 
Gelb & Sigler, 1990; Freemont, Anderson, Wilson, 
Dennis & Xuong, 1993) and mammals (Dijkstra, Kalk, 
Hol & Drenth, 1981; Dijkstra, Renetseder, Kalk, Hol & 
Drenth, 1983; Wery et al., 1991). Using the nomencla- 
ture and numbering scheme of Heinrikson, Kreuger & 
Keim (1977), myotoxin II is classified as a class II PLA. 
The structure is stabilized by seven disulfide bridges 
(27:125, 29:45, 44:105, 50:133, 51:98, 61:91, 84:96) and 
50 ! 
: i ,, 
25_i..~ .... i..................... = ................ i~...~-..~ .............. 
0 ~ ~ ,  ,', ~.' ! , iA '~  • ~, / : ~., 
'0 '.~ '2o '3o ~0 ~0 ;0 '70 80 bo '.~ 
5O 
.~ 25 
L 
~o . . . .  i 
~ I i ! i 
,~ 100 t110 120 30 140 150 160 170 ~180 190 2(h') 
..... 
25 ~ " ', 
~ '~ ' t  : t ~ . . . .  ~ / '  A ,', 
i i  ,.i 1: ' " :',i! ,' '"\ i~,  " '  
0 
L200 '21() ~220 '230 1240 i250 260  ~80 '2SRI '300 1270 
Fig. 3. Superpositioning of the Ca atoms from, myotoxin II molecule 1
(thick line), myotoxin II molecule 2 (thin line), and App (dashed 
line). 
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Fig. 2. Distribution of the mean temperature factors as a function of 
residue number. Thick and thin lines represent main-chain a d side- 
chain atoms, respectively. The two molecules in the asymmetric unit 
are numbered sequentially from 1 to 121 and 201 to 321. 
comprises an N-terminal a-helix (residues 2-12), linked 
by loops and a single helical turn to the first long a-helix 
(40-55). A short antiparallel ]3-sheet (75-84), referred to 
as the /~-wing, leads to a second long helix (90-107) 
which is antiparailel to the first. The loop region (25-35) 
corresponds to the calcium-binding loop in the enzymi- 
cally active PLA2's. 
The deviations of bond lengths and angles from ideal 
values for the model are presented in Table 1. The 
Ramachandran plot (not shown) (Ramachandran &
Sashisekharan, 1965) indicates the presence of two 
outliers. Fig. 2 illustrates the distribution of the 
temperature factors for sequentially numbered main- 
chain and side-chain atoms. The outliers in the 
Ramachandran plot lie in the same loop region in each 
of the two molecules (78-80 sequential numbering, 88- 
90 homology numbering). The loops contain a proline, 
possess higher than average temperature factors and are 
characterized by poor electron density. 
Fig. 3 and Table 2 present he results of the super- 
positioning using the Ca atoms of the homologous core 
(Renetseder, Brunie, Dijkstra, Drenth & Sigler, 1985) 
from the two monomers in the asymmetric unit of 
myotoxin II and the structure of the Lys49 variant from 
App. The structures of the two monomers are very 
similar, and the largest deviations between the structures 
of myotoxin II and the Lys49 variant from App are 
mainly in the calcium-binding and the C-terminal oop 
regions. 
Dimer interactions 
Myotoxin II exists as a highly stable dimer in solution 
(Francis et al., 1991), and in the crystal structure the two 
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Table 2. Statistics derived from superpositioning the Cot 
atoms of the myotoxin II molecules 1 and 2 with App 
utilizing the homologous core as defined by Renetseder 
et al. (1985) 
First Second 
molecule molecule R.m.s. deviation 
Myotoxin I1 Myotoxin II 0.587 
molecule ! molecule 2 
Myotoxin II App 1.048 
molecule I
Myotoxin II App I. 100 
molecule 2 
Table 3. Amino-acid side chains participating in the 
formation of the dimer 
Maximum contact distance considered for analysis = 3.5 ,~ 
From To Distance (~,) 
Glul20EI Lys280 NZ 3.2 
Glu 12 OE2 Lys280 NZ 3.0 
Trp77 NE1 Gin211 O 3.0 
Trp77 NEI Glu212 O 3.5 
Lys80 NZ Glu212 OEI 2.9 
Lys80 NZ Glu212 OE2 2.9 
Lys80 NZ Lys280 O 3.4 
Lys80 O Lys280 NZ 3.0 
monomers are related by an almost perfect twofold 
symmetry axis (rotation angle 179.7°). We propose this 
crystallographic interaction is representative of the 
dimeric interaction in solution. 
In catalytically active PLAz's, it has been suggested 
that dimerization is essential and enhances enzymatic 
activity (Cho, Tomasselli, Heinrickson & Kezdy, 1988; 
Tomasselli et al., 1989). Myotoxin II presents a novel 
dimeric form for PLA2 molecules, as illustrated in Fig. 
4(a). The fl-wing regions interact closely with each other 
and the putative 'catalytic' sites are exposed to the 
solvent. These extensive and intimate diad interactions 
are mainly between the amino acids located at the C- 
terminal end of the first helix and the loop region 
preceeding the first fl-strand of the /3-wing. Fig. 4(b) 
shows this region in more detail, and illustrates the 
interactions stabilizing the dimer. Table 3 provides a list 
of the amino-acid side chains participating in the 
stabilization of the dimer. 
In contrast o the crystal structures of other PLA2's, 
where the fl-wing region is disordered (Scott et al., 
1992), these regions are well defined in the electron 
density of myotoxin II, presumably due to the extensive 
interactions which stabilize the dimer (Table 3). The 
amino acids involved in these interactions in the structure 
of myotoxin II are conserved in App Lys49 and are in the 
same relative orientations with the exception of the 
indole ring of Trp77. Interestingly, App Lys49 exists as a 
monomer in the two crystal structures reported (Holland 
et al., 1990; Scott et al., 1992), and this region has not 
been reported to be involved in the formation of 
intermolecular contacts (Holland et al., 1990; Scott et 
al., 1992). 
In the crystal structure of dimeric PLA2 from Crotalus 
atrox, the monomers are also related by a twofold 
rotational symmetry axis. However, in this case the 
interaction results in the formation of a very different 
dimer in which the catalytic residues are shielded from 
the solvent and face an internal cavity, and the fl-wing 
region is fully exposed to the solvent. Additionally, the 
catalytically essential residue Asp49 forms hydrogen 
bonds between the two molecules (Brunie et al., 1985). If 
this structure does indeed represent the functional dimer, 
and dimerization is essential for activity (Shen et al., 
1975), it is unclear how the dimers dissociate or reorient 
to expose the catalytic site to facilitate calcium binding 
(Brunie et al., 1985). The C. atrox crystallographic dimer 
is stabilized by five hydrogen bonds and hydrophobic 
interactions. Of these, out of a total of ten residues 
involved only three (Tyr52, Asn67 and Lys69) are 
conserved in myotoxin II. The myotoxin II dimer is 
stabilized by intermolecular hydrogen bonds involving 
Glnl2, Trp77 and Lys80 (see Table 3), none of these 
residues are conserved in C. atrox PLA2. 
The calcium-binding loop 
In catalytically active PLA2's, calcium is an essential 
cofactor. The ligated Ca 2÷ in the crystal structure of 
bovine pancreatic PLA2 (Dijkstra et al., 1981) is situated 
. 7 
~,~J 212 
(a) 
(b) 
. . , .  77 
Fig. 4(a). A stereoview of the dimer. Interactions are mainly between 
the amino acids located at the C-terminal end of the first helix and the 
loop region preceeding the first fl-strand of the fl-wing. (b) A 
close-up view of this region in greater detail illustrating the side- 
chain and main-chain interactions which stabilize the dimer. 
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0.2,~ from the position of the e-amino group in the 
superimposed App Lys49 structure (Scott et al., 1992). 
Fig. 5 compares the same loop region from the myotoxin 
II [molecules 1 and 2 shown in Figs. 5(a) and 5(b), 
respectively] to that of App Lys49 PLA [Fig. 5(c)]. For 
comparison, Fig. 5(d) shows the homologous loop region 
from the catalytically active Asp49 Naja naja atra PLA2. 
The Lys49 e-amino groups in the three loop structures 
shown in Figs. 5(a)-(c) occupy the volume taken by the 
Ca 2+ ion in Fig. 5(d). 
Comparison of the loop regions in the Lys49 PLA's 
shows that in myotoxin II Val31, Leu32 and Gly33 
substitute for Trp, Gly and His, resulting in a very 
diferent loop conformation. Two of the three hydrogen 
bonds observed in the App Lys49 PLA2 (Holland et al., 
LY 33 ~ Y  33 
~ S  249 233 
(a) 
(b) 
~~S 249 233 
~ 33 
49 
(c) 
49 
31 _ ) __ . . _~LV ~ 
(d) 
Fig. 5. Calcium-binding loop regions (amino acids 28-33 and 49) from 
myotoxin II molecule 1 (a), molecule 2 (b), App (c) and the 
catalytically active PLA2 from Naja naja atra, which illustrates the 
coordination of the Ca 2÷ ion (shown as a full sphere) in which a 
Asp49 replaces Lys (d). 
1990) are conserved in both the monomers of myotoxin 
II. Furthermore, in the App Lys49 structure, the 
coordination of the amino group is completed by a 
tightly bound water molecule. In myotoxin II, no solvent 
atoms were observed in this region. 
Discussion 
The structure of myotoxin II, a myotox!c Lys49 variant 
PLA2 from B. asper, determined at 2.8 A is very similar 
to the Lys49 variant from App (Holland et al., 1990; 
Scott et al., 1992) with which it shares 75% sequence 
identity (Francis et al., 1991). In agreement with 
previous work, we find that the substitution of Asp49 
by Lys49 results in the e-amino group of Lys49 
occupying the site normally filled by the calcium ion. 
This substitution and the consequent loss of Ca2+-binding 
ability, results in the lack of hydrolytic activity observed 
in these proteins (Maraganore et al., 1984, Francis et al, 
1991). Site-directed substitution of Asp49 by Lys in 
porcine pancreatic PLA2 also resulted in complete loss of 
catalytic activity (van den Berg et al., 1989). 
In all class I/II phospholipases, the amino-acid 
residues His48, Tyr52, Tyr73 and Asp99 are fully 
conserved. The Asp99/His48 pair, in conjunction with 
a bound water molecule, acts as a catalytic triad. 
Additionally, Asp99 is hydrogen bonded to the Tyr52 
and Tyr73 side chains. This pattern of interconnected 
hydrogen bonds is referred to as the catalytic network 
(Kuipers, Franken, Hendricks, Verheij & de Haas, 1990). 
The relative positions of the amino acids in the catalytic 
network between the active PLA2's and the inactive 
myotoxin II are structurally conserved (Fig. 6). Also 
shown in Fig. 6 is position 68, which in N. naja atra 
PLA2 and myotoxin II are occupied by Pro, but in the 
case of App Lys49 PLA, is substituted by His. The 
functional significance of this substitution is unknown. 
Myotoxin II forms a stable dimer in solution (Francis 
et al., 1991), and we propose that the arrangement of the 
two monomers in the crystallographic asymmelric unit is 
S48 .. .IS 48 
Fig. 6. Results of the superpositioning of the amino acids forming the 
catalytic network. Molecules 1 and 2 from B. asper are shown as 
thick and thin lines, dashed and dotted lines represent the Asp49 
PLA2 from Naja naja atra and the App Lys49, respectively. 
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representative of the dimer in solution. The interactions 
between the monomers indicates a novel dimeric form in 
which the/5-wing regions from each monomer interact, 
and the proposed lipid-binding face and residues 
involved in catalysis are exposed to the solvent. 
Although the amino acids forming the contacts in the 
myotoxin II dimer are conserved in App Lys49, and are 
in approximately the same relative orientations in the two 
crystal structures (Holland et al., 1990; Scott et al., 
1992), they were not found to be involved in inter- 
molecular interactions in the crystal structure of mono- 
meric App. This suggests that other factors are involved 
in the formation and stabilization of the dimer. A number 
of studies have implicated the importance of the 
acylation of lysine residues as a mechanism to promote 
dimerization and a concommitant 200-fold increase in 
catalytic activity (Cho et al., 1988; Tomasselli et al., 
1989); however, close examination of the electron- 
density map does not reveal the presence of acyl groups 
either on the lysines at the dimer interface, or in any other 
regions of the molecule. Table 3 shows that the dimer is 
stabilized by a total of eight salt bridges and hydrogen 
bonds between the two monomers, which has been 
shown to be stable in both 0.1% sodium dodecyl sulfate 
at 358K and 2M urea (Francis et al., 1991). It is thus 
unlikely that such a stable structure can dissociate in 
solution. 
Although myotoxin II is devoid of phospholipase 
activity, it retains potent myotoxic activity, causing 
myonecrosis by affecting the integrity of the plasma 
membrance of muscle fibers (Lomonte & Guttierez, 
1989). Attempts using amino-acid sequence comparisons 
to identify the region of the PLA2 responsible for 
myotoxicity (Kini & Iwanaga, 986) have not been 
successful in predicting myotoxity in myotoxin II 
(Francis et al., 1991). The same degree of myotoxicity 
and edema-inducing activity exists between myotoxins I 
and II (Gutierrez, Ownby & Odell, 1984), suggesting that 
phospholipase activity is not essential for these functions. 
Previous comparisons of myotoxic PLA2 amino-acid 
sequences indicate that all have either three or four 
tyrosines between residues 112 and 121, a threonine at 
112, and a lysine at position 38, all of which are not 
found in non-myotoxic PLA2 sequences (Francis et al., 
1991). Based on the structure of PLA2 from C. atrox, it 
has been suggested that Lys38 lies close to these C- 
terminal tyrosines, and may be implicated in myotoxic 
activity (Francis et al., 1991). Interestingly, we find a 
network of hydrogen bonds in which the fully exposed 
Lysl9 and Tyrl09 from each monomer interact with the 
same amino acids from a symmetry-equivalent molecule. 
We are currently refining the structures of a number of 
other myotoxic PLA2-1ike proteins, and a comparison of 
the models may help to identify the region or regions 
conferring myotoxicity. 
In conclusion, calcium ions are an essential co-factor 
for the hydrolysis of phospholipids by catalytically active 
PLA2's. A calcium-independent mechanism of mem- 
brane damage, without PLA2 activity, has been demon- 
strated for myotoxin II (Rufini et al., 1992). This 
indicates a novel mechanism for membrane damage, 
and the availability of the model for the myotoxin II will 
be useful in providing further insights on this activity. 
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